Roman-Ulrich Müller

@muellerrom.bsky.social

passionate for translational research...kidney disease and beyond...

🧵🧪 STOP-PKD study | Five additional trial sites successfully initiated The STOP-PKD study continues to expand its network across Europe, with five additional trial sites now successfully initiated in the Netherlands, Germany and Austria.

Bild

Paper out on single-cell damage scores.📜Quantify the damage of single podocytes or hepatocytes using their transcriptomes to study degenerative diseases. Big congrats to the Beyer-Lab members Tim Padvitski and Paula Unger 🍾🌟🎉 Thanks to all the fantastic collaborators! www.cell.com/cell-genomic...

Cell-type-specific damage scores reveal kidney and liver disease trajectories in single-cell and spatial transcriptomics

Padvitski, Unger Avila, Chen et al. introduce a single-cell transcriptomic framework that quantifies progressive cellular damage across degenerative disease models. Applied to kidney and liver injury,...

cell.com

🧵🧪 STOP-PKD study | Four additional trial sites activated The STOP-PKD study continues to expand its recruitment network across Europe, with four additional trial sites now initiated: three in Germany and a second centre in Austria.

Bild

We’re excited to share our latest publication in npj Aging on the molecular effects of short-term calorie restriction before living kidney donation. Using proteomics, lipidomics, and cytokine profiling, we found that just 7 days of 50% calorie restriction induced molecular signatures linked to: 🧵

I usually think twice before posting preprints. But this time it’s different. MEDA-PKD is the essence of our work over more than a decade — and, to me, one of the most meaningful contributions I’ve been able to make to biomedical research. 🧵

New publication on hereditary kidney tumors. Our questionnaire-based screening approach (referenced in the German giudeline) has now been validated. A step toward better identification of patients who may benefit from genetic evaluation and personalized care. 📖 academic.oup.com/ckj/advance-...

Hereditary kidney tumor syndromes: structured evaluation of a questionnaire-based approach

AbstractBackground. Up to 8% of renal tumors have a monogenic cause, yet hereditary renal cell carcinoma (hRCC) syndromes such as Von Hippel–Lindau (VHL),

academic.oup.com

🧵 🧬 Help shape the future of ADPKD research Are you living with ADPKD? Your perspective matters. PKD International is part of the ARTICYST Project, a European initiative bringing together research centres and the patient community to improve the future of ADPKD research.

BildBildBildBild